Older women who take menopausal hormone therapy may be at a higher risk of Alzheimer's. A study published in Science Advances ...
For Alzheimer’s, blood tests for p-tau are still useful, but they should not be the only method for diagnosis. A positive ...
Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...
The results of a new study show that suppressing KCTD20, which responds to the neurotransmitter glutamate, activates a mechanism for expelling tau proteins.
"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...
Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, ...
A special edition of the journal Science focuses on women's health, including links between estrogen and dementia, at a time ...
USC Stem Cell scientists discover a new way to rid cells of toxic tau protein in a study involving mice and lab-grown human ...
The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic ...
1d
Clinical Trials Arena on MSNAsceneuron halts Alzheimer’s trial adding to tau-targeting setbacksAfter Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) Q4 2024 Earnings Call Transcript March 4, 2025 Amylyx Pharmaceuticals, Inc.
This article originally appeared in Research Colorado.Research at the University of Denver is showing promise for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results